SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950133-00-000552
Filing Date
2000-02-15
Accepted
2000-02-15 00:00:00
Documents
1
Group Members
BB BIOTECH AGBIOTECH FOCUS S.A.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.1 TO SCHEDULE 13G SC 13G/A 13299
  Complete submission text file 0000950133-00-000552.txt   15339
Mailing Address 275 ARMAND FRAPPIER BLVD LAVAL QUEBEC E6
Business Address 275 ARMAND-FRAPPIER BLVD LAVAL QUEBEC E6 5146811744
BIOCHEM PHARMA INC (Subject) CIK: 0000867202 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E6 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-45089 | Film No.: 545065
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O BAKER & MCKENZIE 815 CONNECTICUT AVENUE NW WASHINGTON DC 20006
Business Address C/O BAKER & MCKENZIE 815 CONNECTICUT AVENUE NW WASHINGTON DC 20006 2028351882
BB BIOTECH AG (Filed by) CIK: 0000924223 (see all company filings)

State of Incorp.: DC | Fiscal Year End: 1231
SIC: 0000